Delivery Order SPE2DB20D2104-SPE2DB22FS74Y
- Not listed
- This federal contract award, valued at $14,876.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, which does not have a set-aside designation, is a Delivery Order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,974.54 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 6, 2023 with a completion date of November 7, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $15,178.14, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, with a performance period ending on May 2, 2023. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The firm-fixed-price delivery order, valued at $11,293.26, has an ultimate completion date of September 21, 2021. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical. The...
- This federal contract award issued by the Defense Logistics Agency (DLA) is a Delivery Order to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $12,028.10 firm-fixed-price contract is for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The order has a completion date of June 23, 2022. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, with a ceiling value of $4,917.25, is for the delivery of the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The award is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,773.10 firm-fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical products...
- This federal contract award, valued at $29,528.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $11,783.89 and an ultimate completion date of November 16, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $21,297.62, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS74YDelivery Order
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $10,944.65, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract does not have a set-aside designation, indicating open competition. Cencora, Inc. and its subsidiaries serve as critical suppliers of pharmaceutical products and medical supplies to various government agencies, particularly supporting the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 5/17/22 |